1
|
Patel R, Skanthesh L, Zaveri V, Padikkal V, Ghosh OSN. The Ayurvedic Management of Fungal Sinusitis in Standalone Settings: A Case Report. Clin Case Rep 2025; 13:e70068. [PMID: 39868407 PMCID: PMC11761411 DOI: 10.1002/ccr3.70068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2024] [Revised: 11/21/2024] [Accepted: 12/15/2024] [Indexed: 01/28/2025] Open
Abstract
A 42-year-old female with left nasal blockage, facial numbness, upper palate pain, and headache was diagnosed with fungal ball sinusitis via CT scan. Refusing surgery, she opted for Ayurveda. Comprehensive treatment led to complete symptom resolution and a clear CT scan at 3 months.
Collapse
Affiliation(s)
- Rajanikant Patel
- Agnivesh Ayurved HospitalSuratIndia
- Personalized Precision Health Systems FoundationBengaluruKarnatakaIndia
| | - Lakshmanan Skanthesh
- Personalized Precision Health Systems FoundationBengaluruKarnatakaIndia
- Center for Advanced Studies and Integrated Research in AyurvedaThrissurKeralaIndia
| | - Vishal Zaveri
- Sun Scan Radiology & Imaging CentreSuratGujaratIndia
| | - Vinayak Padikkal
- Personalized Precision Health Systems FoundationBengaluruKarnatakaIndia
- Center for Advanced Studies and Integrated Research in AyurvedaThrissurKeralaIndia
| | - Oriparambil Sivaraman Nirmal Ghosh
- Personalized Precision Health Systems FoundationBengaluruKarnatakaIndia
- Center for Advanced Studies and Integrated Research in AyurvedaThrissurKeralaIndia
| |
Collapse
|
2
|
Huang T, Linklater D, Li X, Gamage SSB, Alkazemi H, Farrugia B, Heath DE, O'Brien-Simpson NM, O'Connor AJ. One-Step Synthesis of Antimicrobial Polypeptide-Selenium Nanoparticles Exhibiting Broad-Spectrum Efficacy against Bacteria and Fungi with Superior Resistance Prevention. ACS APPLIED MATERIALS & INTERFACES 2024; 16:68996-69010. [PMID: 39636760 DOI: 10.1021/acsami.4c17157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/07/2024]
Abstract
The growing threat of antimicrobial resistance (AMR) necessitates innovative strategies beyond conventional antibiotics. In response, we developed a rapid one-step method to sythesize antimicrobial peptide (AMP) ε-poly-L-lysine stabilized selenium nanoparticles (ε-PL-Se NPs). These polycrystalline NPs with highly positive net surface charges, exhibited superior antimicrobial activity against a broad panel of pathogens, including the Gram-positive and -negative bacteria Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa and their drug-resistant counterparts, as well as the yeast Candida albicans. Notably, 10PL-Se NPs exhibited 6-log reduction of methicillin-resistant S. aureus (MRSA) at a concentration of 5 μg/mL within 90 min, with minimum bactericidal concentrations (MBCs) below 50 μg/mL for all tested bacterial strains. The minimum fungicidal concentration (MFC) of 10PL-Se NPs against C. albicans was 26 ± 10 μg/mL. Crucially, bacteria exposed to ε-PL-Se NPs exhibited significantly delayed resistance development compared to the conventional antibiotic kanamycin. S. aureus developed resistance to kanamycin after ∼72 generations, whereas resistance to 10PL-Se NPs emerged after ∼216 generations. Remarkably, E. coli showed resistance to kanamycin after ∼39 generations but failed to develop resistance to 10PL-Se NPs even after 300 generations. This work highlights the synergistic interactions between ε-PL and Se NPs, offering a robust and scalable strategy to combat AMR.
Collapse
Affiliation(s)
- Tao Huang
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Denver Linklater
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Xin Li
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Shaveen S B Gamage
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Hazem Alkazemi
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Brooke Farrugia
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Daniel E Heath
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Neil M O'Brien-Simpson
- ACTV Research Group, Melbourne Dental School and The Bio21 Institute of Molecular Science and Biotechnology, The University of Melbourne, Melbourne, Victoria 3010, Australia
| | - Andrea J O'Connor
- Department of Biomedical Engineering, Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia
- Aikenhead Centre for Medical Discovery (ACMD), St Vincent's Hospital Melbourne Fitzroy, Melbourne, Victoria 3065, Australia
| |
Collapse
|
3
|
Garnacho-Montero J, Barrero-García I, León-Moya C. Fungal infections in immunocompromised critically ill patients. JOURNAL OF INTENSIVE MEDICINE 2024; 4:299-306. [PMID: 39035612 PMCID: PMC11258510 DOI: 10.1016/j.jointm.2024.01.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 01/01/2024] [Accepted: 01/02/2024] [Indexed: 07/23/2024]
Abstract
Diverse pathogenic fungi can produce severe infections in immunocompromised patients, thereby justifying intensive care unit (ICU) admissions. In some cases, the infections can develop in immunocompromised patients who were previously admitted to the ICU. Aspergillus spp., Pneumocystis jirovecii, Candida spp., and Mucorales are the fungi that are most frequently involved in these infections. Diagnosis continues to be challenging because symptoms and signs are unspecific. Herein, we provide an in-depth review about the diagnosis, with emphasis on recent advances, and treatment of these invasive fungal infections in the ICU setting.
Collapse
Affiliation(s)
- José Garnacho-Montero
- Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Irene Barrero-García
- Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, Spain
| | - Cristina León-Moya
- Unidad Clínica de Cuidados Intensivos, Hospital Universitario Virgen Macarena, Sevilla, Spain
| |
Collapse
|
4
|
Yusuf E, Paul M. Seeing is Believing. Clin Microbiol Infect 2024; 30:286-287. [PMID: 38182049 DOI: 10.1016/j.cmi.2023.12.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2023] [Revised: 12/12/2023] [Accepted: 12/31/2023] [Indexed: 01/07/2024]
Affiliation(s)
- Erlangga Yusuf
- Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Mical Paul
- Infectious Diseases Institute, Rambam Health Care Campus, Haifa, Israel; Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
| |
Collapse
|